Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Piperacillin sodium; Tazobactam sodium
Milpharm Ltd
J01CR05
Piperacillin sodium; Tazobactam sodium
4gram ; 500mg
Powder for solution for infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010104; GTIN: 8901175032006
OBJECT 1 PIPERACILLIN/TAZOBACTAM 4 G / 0.5 G POWDER FOR SOLUTION FOR INJECTION OR INFUSION Summary of Product Characteristics Updated 08-Aug-2017 | Aurobindo Pharma - Milpharm Ltd. 1. Name of the medicinal product Piperacillin/Tazobactam 4 g / 0.5 g powder for solution for infusion 2. Qualitative and quantitative composition Each vial contains piperacillin (as sodium salt) equivalent to 4g piperacillin and tazobactam as sodium salt equivalent to 0.5g tazobactam. One vial of powder for solution forinfusion contains 9.4 mmol (216mg) of sodium. 3. Pharmaceutical form Powder for solution for infusion. White to off-white powder. 4. Clinical particulars 4.1 Therapeutic indications Piperacillin/Tazobactam is indicated for the treatment of the following infections in adults and children over 2 years of age (see sections 4.2 and 5.1): ADULTS AND ADOLESCENTS - Severe pneumonia including hospital-acquired and ventilator-associated pneumonia - Complicated urinary tract infections (including pyelonephritis) - Complicated intra-abdominal infections - Complicated skin and soft tissue infections (including diabetic foot infections) Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. Piperacillin/Tazobactam may be used in the management of neutropenic patients with fever suspected to be due to a bacterial infection. CHILDREN 2 TO 12 YEARS OF AGE - Complicated intra-abdominal infections Piperacillin/Tazobactam may be used in the management of neutropenic children with fever suspected to be due to a bacterial infection. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 Posology and method of administration POSOLOGY The dose and frequency of Piperacillin/Tazobactam depends on the severity and localisation of the infection and expected pathogens. _Adult and adolescent patients _ _Infections _ The usual dose is 4 g piperacillin / 0.5 g tazobactam given every 8 hours. For nosocomial pneumon Read the complete document